Mycobacterium tuberculosis Impairs Dendritic Cell Functions through the Serine Hydrolase Hip1
暂无分享,去创建一个
B. Pulendran | J. Rengarajan | S. Khader | L. Monin | Ranjna Madan-Lala | J. K. Sia | R. King | T. Adékambi | Rebecca L. King | Jyothi Rengarajan
[1] K. Mills,et al. Dendritic cells and other innate determinants of T helper cell polarisation. , 2013, Trends in immunology.
[2] Kelly A. Prendergast,et al. Dendritic cell subsets in mycobacterial infection: control of bacterial growth and T cell responses. , 2013, Tuberculosis.
[3] D. Sherman,et al. Early Secreted Antigenic Target of 6-kDa Protein of Mycobacterium tuberculosis Primes Dendritic Cells To Stimulate Th17 and Inhibit Th1 Immune Responses , 2012, The Journal of Immunology.
[4] J. Ernst. The immunological life cycle of tuberculosis , 2012, Nature Reviews Immunology.
[5] F. Re,et al. Mycobacterium tuberculosis Hip1 Dampens Macrophage Proinflammatory Responses by Limiting Toll-Like Receptor 2 Activation , 2011, Infection and Immunity.
[6] A. Cooper,et al. Cellular response to mycobacteria: balancing protection and pathology. , 2011, Trends in immunology.
[7] John Steel,et al. Programming the magnitude and persistence of antibody responses with innate immunity , 2010, Nature.
[8] S. Behar,et al. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.
[9] J. Pedrosa,et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis , 2010, The Journal of experimental medicine.
[10] J. Curtsinger,et al. Inflammatory cytokines as a third signal for T cell activation. , 2010, Current opinion in immunology.
[11] S. Nakae,et al. Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung , 2010, The Journal of Immunology.
[12] D. Schnappinger,et al. Mycobacterial survival strategies in the phagosome: defence against host stresses , 2009, Cellular microbiology.
[13] P. Ricciardi-Castagnoli,et al. Spotlight on mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge? , 2009, EMBO molecular medicine.
[14] D. Schnappinger,et al. Acid-Susceptible Mutants of Mycobacterium tuberculosis Share Hypersusceptibility to Cell Wall and Oxidative Stress and to the Host Environment , 2008, Journal of bacteriology.
[15] M. Glickman,et al. Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infection , 2008, The Journal of experimental medicine.
[16] Alan D. Roberts,et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes , 2008, Proceedings of the National Academy of Sciences.
[17] R. Hunter,et al. The ΔfbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells , 2008, Cellular microbiology.
[18] R. Wilkinson,et al. Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response1 , 2008, The Journal of Immunology.
[19] J. Ernst,et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs , 2008, The Journal of experimental medicine.
[20] L. Glimcher,et al. Mycobacterium tuberculosis Rv2224c modulates innate immune responses , 2008, Proceedings of the National Academy of Sciences.
[21] J. Ernst,et al. Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo1 , 2007, The Journal of Immunology.
[22] W. Bishai,et al. Characterization of a Novel Cell Wall-anchored Protein with Carboxylesterase Activity Required for Virulence in Mycobacterium tuberculosis* , 2007, Journal of Biological Chemistry.
[23] S. Hickman,et al. Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs1 , 2007, The Journal of Immunology.
[24] Kamlesh Bhatt,et al. Host Innate Immune Response to Mycobacterium tuberculosis , 2007, Journal of Clinical Immunology.
[25] B. Pulendran,et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. , 2006, The Journal of clinical investigation.
[26] I. Humphreys,et al. A role for dendritic cells in the dissemination of mycobacterial infection. , 2006, Microbes and infection.
[27] W. Jacobs,et al. Potent Inhibition of Macrophage Responses to IFN-γ by Live Virulent Mycobacterium tuberculosis Is Independent of Mature Mycobacterial Lipoproteins but Dependent on TLR21 , 2006, Journal of Immunology.
[28] A. Sher,et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis , 2005, The Journal of experimental medicine.
[29] S. Behar,et al. In Vivo Depletion of CD11c+ Cells Delays the CD4+ T Cell Response to Mycobacterium tuberculosis and Exacerbates the Outcome of Infection1 , 2005, The Journal of Immunology.
[30] E. Rubin,et al. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Harding,et al. Prolonged Toll-Like Receptor Signaling by Mycobacterium tuberculosis and Its 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Induced Regulation of Selected Genes in Macrophages , 2004, Infection and Immunity.
[32] M. Reed,et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.
[33] John T. Belisle,et al. Mycobacterium tuberculosis LprG (Rv1411c): A Novel TLR-2 Ligand That Inhibits Human Macrophage Class II MHC Antigen Processing1 , 2004, The Journal of Immunology.
[34] Simeone Marino,et al. Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis 1 , 2004, The Journal of Immunology.
[35] S. Fortune,et al. Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.
[36] M. Netea,et al. Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells , 2004, The Journal of Immunology.
[37] S. Hickman,et al. Cutting Edge: A New Approach to Modeling Early Lung Immunity in Murine Tuberculosis1 , 2004, The Journal of Immunology.
[38] M. Kapsenberg. Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.
[39] C. Harding,et al. The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2 , 2003, Infection and Immunity.
[40] J. Flynn,et al. Immune evasion by Mycobacterium tuberculosis: living with the enemy. , 2003, Current opinion in immunology.
[41] P. Haslett,et al. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. , 2003, The Journal of infectious diseases.
[42] O. Schwartz,et al. DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.
[43] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[44] C. Dascher,et al. Dissemination of Mycobacterium tuberculosis Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity , 2002, Infection and Immunity.
[45] A. Al-ghonaium,et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. , 2002, American journal of human genetics.
[46] L. Fiette,et al. Dendritic Cells Are Host Cells for Mycobacteria In Vivo That Trigger Innate and Acquired Immunity1 , 2002, The Journal of Immunology.
[47] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[48] JoAnne L. Flynn,et al. Fate of Mycobacterium tuberculosis within Murine Dendritic Cells , 2001, Infection and Immunity.
[49] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[50] J. Casanova,et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.
[51] Simon C Watkins,et al. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. , 1997, Journal of immunology.
[52] T. Kaisho,et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages , 2007, Nature Immunology.
[53] David G. Russell,et al. Who puts the tubercle in tuberculosis? , 2007, Nature Reviews Microbiology.
[54] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[55] I. Orme,et al. Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .
[56] J. Blenis,et al. Kinase-Mitogen-Activated Protein Kinase Signal-Regulated Modulation of Extracellular Distinct Th Responses via Differential Agonists Instruct Dendritic Cells to Induce Cutting Edge: Different Toll-Like Receptor , 2022 .